dermatan sulfate has been researched along with Embolism, Pulmonary in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (6.90) | 18.7374 |
1990's | 15 (51.72) | 18.2507 |
2000's | 10 (34.48) | 29.6817 |
2010's | 2 (6.90) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babović, I; Karapandzić, VP; Plesinac, S | 1 |
Alings, AM; de Bree, LC; van Wijngaarden, P | 1 |
Myers, B; Strong, J; Westby, J | 1 |
Opatrny, L; Warner, MN | 1 |
Bourke, M; Lavalee, G; Mesana, T; Rubens, FD; Ruel, MA | 1 |
Antonijevic, NM; Calija, B; Kovac, M; Mikovic, D; Milosevic, RA; Obradovic, SD; Perunicic, J; Savic, NB; Stanojevic, M; Vasiljevic, Z | 1 |
Piepenbrock, S; Rahe-Meyer, N; Raymondos, K; Weilbach, C | 1 |
Babaev, A; Belway, D; Henley, B; Mesana, T; Rubens, FD | 1 |
Bastien, O; Bauer, C; Ffrench, P; Hercule, C; Jegaden, O; Lehot, JJ; Vichova, Z | 1 |
Harenberg, J; Kübler, W; Schwarz, F; Zimmermann, R | 1 |
Bucknall, T; Cade, J; Gallus, A; Hepburn, S; Maas, M; Magnani, H; Ockelford, P; Porteous, F; Stevens, J | 1 |
Banga, JD; Brouwer, CB; de Valk, HW; Hart, HC; Meuwissen, OJ; Nieuwenhuis, HK; Sixma, JJ; van Hessen, MW; Wester, JW | 1 |
Cohen, AT; Cooper, DJ; Das, SK; Edmondson, RA; Kakkar, VV; Melissari, E; Phillips, MJ; Skinner, JA; Thomas, EM | 1 |
Kleinschmidt, S; Seyfert, UT | 1 |
Görres, G; Marbet, GA; Ritz, R; Stöckli, TC; Walther, A | 1 |
Augusseau-Richard, MP; Charbonnier, B; Dessenne, X; Pacouret, G; Pagot, O | 1 |
Boneu, B | 1 |
Claeys, L; Ehringer, H; Huk, I; Koppensteiner, R; Kyrle, PA; Minar, E; Muhm, M; Polterauer, P; Stümpflen, A | 1 |
Buchwald, AB; Emig, U; Meyer, T | 1 |
Bergqvist, D | 2 |
Mazet, E; Piot, M; Tardy, B; Tardy-Poncet, B; Viallon, A | 1 |
Wille-Jørgensen, P | 1 |
Warkentin, TE | 1 |
Counsell, C; Sandercock, P | 1 |
Bergqvist, D; Lindblad, B; Mätzsch, T | 1 |
ten Cate, JW | 1 |
Turpie, AG | 1 |
Duckert, F; Marbet, GA; Zbinden, B | 1 |
8 review(s) available for dermatan sulfate and Embolism, Pulmonary
Article | Year |
---|---|
New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
Topics: Anticoagulants; Antithrombin III; Binding Sites; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Multicenter Studies as Topic; Oligosaccharides; Postoperative Complications; Pulmonary Embolism; Recurrence; Thrombin; Thrombophlebitis | 1996 |
[Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Femoral Vein; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iliac Vein; Plasminogen Activators; Pulmonary Embolism; Recurrence; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Urokinase-Type Plasminogen Activator; Vena Cava Filters; Vena Cava, Inferior | 1997 |
Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Drug Administration Schedule; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1998 |
New therapeutic options in DVT prophylaxis.
Topics: Anesthesia, Conduction; Anticoagulants; Bandages; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Logistic Models; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Venous Thrombosis | 2000 |
Venous thromboembolism in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Humans; Leg; Pulmonary Embolism; Thrombocytopenia; Venous Thrombosis; Warfarin | 2000 |
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Topics: Acute Disease; Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Databases, Factual; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Odds Ratio; Pulmonary Embolism; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome; Venous Thrombosis | 2002 |
Glycosaminoglycans in prophylaxis against venous thromboembolism.
Topics: Dermatan Sulfate; Dihydroergotamine; Glycosaminoglycans; Heparin, Low-Molecular-Weight; Humans; Pentosan Sulfuric Polyester; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1992 |
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1992 |
7 trial(s) available for dermatan sulfate and Embolism, Pulmonary
Article | Year |
---|---|
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Elective Surgical Procedures; Female; Gastrointestinal Neoplasms; Glycosaminoglycans; Hematologic Tests; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis | 1993 |
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Drug Administration Schedule; Drug Combinations; Female; Hemorrhage; Heparin; Heparinoids; Heparitin Sulfate; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Pulmonary Embolism; Thromboembolism; Treatment Outcome | 1995 |
A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Dermatan Sulfate; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Phlebography; Postoperative Complications; Pulmonary Embolism; Reference Values; Risk Factors; Thrombophlebitis | 1994 |
Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Female; Gangrene; Heparin; Heparitin Sulfate; Humans; Middle Aged; Phenprocoumon; Platelet Activation; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Recurrence; Systemic Inflammatory Response Syndrome; Thrombocytopenia; Thromboembolism; Thrombophlebitis | 1995 |
Orgaran in hip fracture surgery.
Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Incidence; Male; Postoperative Complications; Pulmonary Embolism; Scandinavian and Nordic Countries; Single-Blind Method; Thrombophlebitis; United States; Warfarin | 1992 |
Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Dihydroergotamine; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Hip Prosthesis; Humans; Incidence; Pulmonary Embolism; Single-Blind Method; Thrombophlebitis; Treatment Outcome | 1992 |
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1992 |
15 other study(ies) available for dermatan sulfate and Embolism, Pulmonary
Article | Year |
---|---|
Successful pregnancy after pulmonary embolism and heparin-induced thrombocytopenia--case report.
Topics: Acenocoumarol; Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Female; Fibrinolytic Agents; Gestational Age; Heparin; Heparitin Sulfate; Hirudins; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pulmonary Embolism; Recombinant Proteins; Thrombocytopenia; Venous Thrombosis | 2013 |
Heparin-induced thrombocytopenia after ICD-lead flushing.
Topics: Antibodies; Anticoagulants; Cardiomyopathy, Dilated; Chondroitin Sulfates; Defibrillators, Implantable; Dermatan Sulfate; Female; Follow-Up Studies; Heparin; Heparitin Sulfate; Humans; Immunoglobulin G; Middle Aged; Platelet Aggregation; Platelet Factor 4; Postoperative Complications; Pulmonary Embolism; Thrombocytopenia; Treatment Outcome; Venous Thromboembolism | 2014 |
Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction.
Topics: Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Eruptions; Emergencies; Female; Heparin; Heparitin Sulfate; Humans; Infant, Newborn; Injections, Subcutaneous; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, High-Risk; Pregnancy, Multiple; Puerperal Disorders; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Warfarin | 2003 |
Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Neoplasms; Pulmonary Embolism; Retrospective Studies; Risk Factors; Thrombocytopenia; Thrombosis; Venous Thrombosis | 2004 |
Delayed thrombin generation with hirudin anticoagulation during prolonged cardiopulmonary bypass.
Topics: Aged; Anticoagulants; Blood Coagulation; Cardiopulmonary Bypass; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Endarterectomy; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Hypertension, Pulmonary; Plasma; Platelet Transfusion; Pulmonary Embolism; Recombinant Proteins; Thrombectomy; Thrombin; Thrombocytopenia; Time Factors; Warfarin | 2005 |
Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin.
Topics: Arthroplasty, Replacement, Hip; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Resistance; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hip Fractures; Hirudins; Humans; Middle Aged; Partial Thromboplastin Time; Plasma; Plasmapheresis; Postoperative Complications; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Salvage Therapy; Thrombophilia; Time Factors | 2006 |
Delivery of a healthy child 30 weeks after resuscitation for thromboembolism and treatment with danaparoid: 5-year follow up.
Topics: Anticoagulants; Cardiotonic Agents; Child Development; Child, Preschool; Chondroitin Sulfates; Dermatan Sulfate; Dobutamine; Factor V; Female; Follow-Up Studies; Genetic Predisposition to Disease; Gestational Age; Heparitin Sulfate; Humans; Infant; Infant, Newborn; Mutation; Norepinephrine; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Respiration, Artificial; Vasoconstrictor Agents | 2006 |
Delayed thrombin generation is not associated with fibrinopeptide formation during prolonged cardiopulmonary bypass with hirudin anticoagulation.
Topics: Adult; Anticoagulants; Cardiopulmonary Bypass; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Endarterectomy; Fibrinolytic Agents; Fibrinopeptide A; Heparin; Heparitin Sulfate; Hirudins; Humans; Hypertension, Pulmonary; Hypothermia, Induced; Male; Peptide Fragments; Postoperative Complications; Prothrombin; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Thrombectomy; Thrombin; Thrombosis | 2006 |
Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Echocardiography, Transesophageal; Extracorporeal Membrane Oxygenation; Factor Xa; Heparitin Sulfate; Humans; Iliac Vein; Male; Portal Vein; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed | 2008 |
Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Pulmonary Embolism; Thrombocytopenia; Thrombosis | 1983 |
[Heparin-induced thrombopenia and thrombosis].
Topics: Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fractures, Bone; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Pelvic Bones; Pulmonary Embolism; Thrombocytopenia; Thrombosis | 1996 |
[Anticoagulant therapy in pulmonary embolism].
Topics: Anticoagulants; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Drug Administration Schedule; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Injections, Intravenous; Partial Thromboplastin Time; Pulmonary Embolism; Thrombolytic Therapy; Thrombosis; Treatment Outcome | 1995 |
Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
Topics: Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Dose-Response Relationship, Drug; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Thrombocytopenia; Thrombophlebitis | 1997 |
Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
Topics: Aged; Anticoagulants; Arteries; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fatal Outcome; Heparinoids; Heparitin Sulfate; Humans; Male; Pulmonary Embolism; Thrombocytopenia; Thrombosis | 1998 |
[Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].
Topics: Adolescent; Adult; Antithrombins; Dermatan Sulfate; Female; Glycoproteins; Heparin Cofactor II; Humans; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1988 |